Advertisement

Topics

Roivant to launch disease-focused subsidiaries after raising $1.1B

05:00 EDT 10 Aug 2017 | SmartBrief

Switzerland-based Roivant Sciences, which focuses on forming disease-focused subsidiaries by in-licensing deprioritized compo -More

Original Article: Roivant to launch disease-focused subsidiaries after raising $1.1B

NEXT ARTICLE

More From BioPortfolio on "Roivant to launch disease-focused subsidiaries after raising $1.1B"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...